SCHEMBL7080193

SCHEMBL7080193

NC(=O)CCCCCC(=O)N1CCC(N2CCCC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
GNAI3 P08754 2/20 0.49
GNAO1 P09471 2/20 0.49
GNAI1 P63096 2/20 0.49
ATM Q13315 1/20 0.48
L3MBTL3 Q96JM7 6/20 0.47
L3MBTL1 Q9Y468 6/20 0.46
NPC1 O15118 1/20 0.46
MBTD1 Q05BQ5 4/20 0.45
TP53BP1 Q12888 1/20 0.45
L3MBTL4 Q8NA19 1/20 0.45
TDP1 Q9NUW8 2/20 0.45
MAPT P10636 1/20 0.44
DPP8 Q6V1X1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1334264 0.84 MEN1 (0.68) MEN1KMT2AGNAI3GNAO1GNAI1
SCHEMBL28230108 0.82 ATM (0.71) MEN1KMT2AGNAI3GNAO1GNAI1
SCHEMBL11769367 0.82 ATM (0.71) MEN1KMT2AGNAI3GNAO1GNAI1
SCHEMBL727823 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM
SCHEMBL727385 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM
SCHEMBL2695810 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM
SCHEMBL727876 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM
SCHEMBL729126 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM
SCHEMBL251937 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM
SCHEMBL1160274 0.81 ATM (0.68) MEN1KMT2AGNAI3GNAI1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268454-A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP disclosed
WO-2001074796-A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-10-11 WO disclosed